Undervalued Small Caps With Insider Buying

Results

59

12 new

Smaller, under-the-radar companies, backed by insider buying, presenting a compelling opportunity for investors seeking undervalued gems.

59 companies

	Company	Last Price	7D Return	1Y Return	Market Cap	Analysts Target	Valuation	Growth	Div Yield	Industry
	PAX	US$11.10	-0.4%	-21.1%	US$1.8b	US$15.57	24.4	34.3%	5.9%	Diversified Financials
	UNB	US$23.36	-7.0%	-13.6%	US$109.0m	n/a	1.2	n/a	6.2%	Banks
	APPN	US$27.35	7.9%	-5.6%	US$1.9b	US$26.20	2268.7	108.9%	n/a	Software
	BMRC	US$29.10	0.9%	25.7%	US$484.4m	US$30.40	1.2	106.3%	3.4%	Banks
	KINS	US$20.19	1.4%	26.5%	US$284.9m	US$21.50	9.4	20.8%	1.0%	Insurance
	ANGX	US$4.09	-5.3%	-68.5%	US$814.6m	US$8.00	2.0	59.6%	n/a	Media
	SHBI	US$24.44	5.7%	52.6%	US$798.7m	US$25.75	1.3	8.1%	2.3%	Banks
	RCEL	US$4.61	-9.4%	-19.8%	US$146.2m	US$9.07	2.0	64.1%	n/a	Pharmaceuticals & Biotech
	SMWB	US$7.19	8.1%	-17.2%	US$598.3m	US$5.80	2.2	112.6%	n/a	Software
	MDV	US$17.58	-3.8%	20.1%	US$210.6m	US$18.67	1.1	149.5%	6.8%	Real Estate
	ONT	US$20.48	5.5%	-8.5%	US$717.7m	US$27.00	167.2	98.9%	n/a	Commercial Services
	ILPT	US$9.05	-1.6%	63.9%	US$600.7m	US$10.27	1.3	24.9%	2.2%	Real Estate
	FNLC	US$35.46	4.6%	40.1%	US$398.8m	n/a	1.4	n/a	4.3%	Banks
	AUBN New	US$26.35	-1.6%	-5.4%	US$92.0m	n/a	1.0	n/a	4.1%	Banks
	CBAN New	US$22.21	6.5%	33.6%	US$461.4m	US$25.00	1.2	34.1%	2.2%	Banks
	ANIK	US$15.15	-0.07%	35.8%	US$199.9m	US$17.50	1.7	67.6%	n/a	Pharmaceuticals & Biotech
	UMH	US$15.69	1.3%	-6.0%	US$1.3b	US$19.13	2.3	24.1%	5.7%	Real Estate
	KRO	US$6.19	-8.0%	2.8%	US$705.3m	US$6.50	0.4	5.9%	3.2%	Materials
	ERII	US$8.40	-2.6%	-38.6%	US$439.2m	US$11.00	21.0	16.6%	n/a	Capital Goods
	PBHC New	US$16.00	0.1%	5.2%	US$100.1m	n/a	0.8	n/a	2.5%	Banks
	UAMY New	US$5.21	-10.8%	69.7%	US$803.8m	US$12.56	19.7	43.5%	n/a	Materials
	EMYB	US$22.50	-0.2%	39.8%	US$166.6m	n/a	1.3	n/a	2.1%	Banks
	MRBK	US$20.31	0.2%	36.6%	US$237.8m	US$23.00	1.2	21.5%	2.8%	Banks
	BY	US$39.20	2.8%	43.5%	US$1.7b	US$42.20	1.4	0.5%	1.4%	Banks

Page 1 of 2